1. Home
  2. DFTX vs MAT Comparison

DFTX vs MAT Comparison

Compare DFTX & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

SELL

Current Price

$30.21

Market Cap

5.9B

Sector

N/A

ML Signal

SELL

Logo Mattel Inc.

MAT

Mattel Inc.

SELL

Current Price

$15.15

Market Cap

4.8B

ML Signal

SELL

Company Overview

Basic Information
Metric
DFTX
MAT
Founded
N/A
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
4.8B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
DFTX
MAT
Price
$30.21
$15.15
Analyst Decision
Strong Buy
Buy
Analyst Count
19
15
Target Price
★ $72.83
$18.04
AVG Volume (30 Days)
1.5M
★ 5.2M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.35
Revenue
N/A
★ $5,347,623,000.00
Revenue This Year
N/A
$3.85
Revenue Next Year
N/A
$5.44
P/E Ratio
★ N/A
$11.29
Revenue Growth
★ N/A
N/A
52 Week Low
$14.62
$12.40
52 Week High
$49.70
$22.48

Technical Indicators

Market Signals
Indicator
DFTX
MAT
Relative Strength Index (RSI) 37.55 43.54
Support Level $20.43 $15.09
Resistance Level $38.59 $15.37
Average True Range (ATR) 2.10 0.57
MACD -0.21 -0.09
Stochastic Oscillator 3.34 45.21

Price Performance

Historical Comparison
DFTX
MAT

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

About MAT Mattel Inc.

Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the rest stemming from international markets.

Share on Social Networks: